Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-04 @ 3:42 AM
Study NCT ID:
NCT05286320
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-02
First Post:
2022-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
Sponsor:
Organization: